These results suggest that DAn neurodegeneration in our system, although strongly influenced by the presence of the LRRK2 G2019S mutation, appears to be modulated by the individual genetic background and exhibits incomplete penetrance in L2-NMC samples. Here, LRRK2 is linked to nut midline carcinoma.